INDUSTRY
Life Sciences
& Healthcare
The life sciences and healthcare industry is growing across Central and Eastern Europe. Indeed, the region is poised to become a major centre of healthcare research and manufacturing in the coming years. Many universities conduct cutting-edge life sciences research and there has been a significant increase in companies manufacturing drugs and other healthcare materials in the region. This creates significant opportunities for companies and investors in the region and beyond.
Our experts advise clients on all phases of their projects, from R&D to manufacturing and sales. We can offer help on a wide range of legal issues, including intellectual property and data protection, compliance and enforcement, litigation, transactions and public procurement. We can also help companies navigate the strict regulations governing the industry and advise them on antitrust and competition issues.
References
We advised a major generic drug manufacturer on terminating its cooperation with its leading representative in the Czech Republic, including settling claims arising from contracts.
We provided legal advice relating to a transaction between two global pharmaceutical companies, involving the sale and purchase of business operations within the Czech Republic. Our support covered various aspects of Czech law, including corporate, regulatory, commercial and labour issues, with a strong emphasis on practical implementation.
We advised a UK company providing clinical research services to the pharmaceutical and biotechnology industry, including reviewing their model contracts for clinical trials.
We advised the Czech subsidiary of a global life science company on data protection. This included carrying out a comprehensive internal data protection audit, setting up data privacy processes, drafting and revising data protection documents and acting as the company's external Data Protection Officer.
We supported a global biopharmaceutical company in its bid for a public contract for the supply of medicinal products. This was a pilot public contract implemented by an association of contracting authorities as a joint award with a total value of CZK 232,800,000.
